Study of Arterial Pressure Levels at Consultation in Treated Hypertensive Algerian Patients (Pact Ii Study)

Objective: The main objective was to describe the management of arterial hypertension in Algeria through the distribution of patients treated for HTN, according to predefined arterial pressure levels reached under treatment. Secondary objectives were: To estimate the mean of systolic blood pressure and diastolic blood pressure according to the 6 levels of AP, to evaluate the frequency of BP target reaching according to the s ESC 2018, both in all hypertensive patients treated, as well as in diabetic hypertensive patients treated and in hypertensive patients treated with renal failure. Design and method: The PACT II study is a national, observational, descriptive, cross-sectional, multicenter and noninterventional study of therapeutic strategy, conducted in Algeria on hypertensive patients treated for at least 3 months, followed by 100 specialists and general practitioners. Results: 2000 eligible patients were recruited in the study. 63.5% and 36.4% of patients were female and male respectively. The average age was 62.4 years +/- 10.7. The most affected age group (65.2%) was between 55 to 75 years old. Most of the patients had an elevated blood pressure (BP) with 49.30% at level III AP (130 – 139 mmHg of SBP or 80 – 89 mmHg of DBP), with 49.6% for diabetic patients and 48.8% for nondiabetic patients, then followed by 20.35% at the level IV AP (140 – 159 mm Hg of SBP or 90 – 99 mm Hg of DBP) with 21.4% for diabetic and 18.3% for non-diabetic patients. Also, 47.32% were at AP level III in patients with renal failure. Regarding the achievement of the blood pressure target, it was 17.4% for the overall population with 18,3% for diabetic's patients and only 12.64% for renal failure patients. Conclusions: The PACT II study updated national data on hypertension in Algeria, highlighting important information's on the reality of the management of this disease in routine medical practice.